Your browser doesn't support javascript.
loading
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
Sternberg, Zohara; Sternberg, Daniel; Drake, Allison; Chichelli, Trevor; Yu, Jinhee; Hojnacki, David.
Afiliación
  • Sternberg Z; Department of Neurology, Stroke Center, Buffalo Medical Center, Buffalo, NY, USA.
  • Sternberg D; Department of Neurology, Baird MS Center, Buffalo Medical Center, Buffalo, NY, USA.
  • Drake A; Department of Neurology, Baird MS Center, Buffalo Medical Center, Buffalo, NY, USA.
  • Chichelli T; Department of Neurology, Baird MS Center, Buffalo Medical Center, Buffalo, NY, USA.
  • Yu J; Department of Biostatistics, University of Buffalo, Buffalo, NY, USA.
  • Hojnacki D; Department of Neurology, Baird MS Center, Buffalo Medical Center, Buffalo, NY, USA.
J Neuroimmunol ; 274(1-2): 197-201, 2014 Sep 15.
Article en En | MEDLINE | ID: mdl-25064498

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Inmunológicos / Monitoreo de Drogas / Esclerosis Múltiple Recurrente-Remitente Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroimmunol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Inmunológicos / Monitoreo de Drogas / Esclerosis Múltiple Recurrente-Remitente Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroimmunol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos